Three-Year Overdose Death Decline Signals Treatment Progress Amid FDA Leadership Gap

References

1. 1.Ciccarone, D. (2023). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry, 36(4), 243-250. https://doi.org/10.1097/YCO.0000000000000827
2. 2.Darrow, J. J., & Kesselheim, A. S. (2023). FDA drug regulation in an era of political polarization. New England Journal of Medicine, 388(15), 1345-1347. https://doi.org/10.1056/NEJMp2300825
3. 3.Friedman, J., & Hansen, H. (2023). Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry, 80(2), 134-141. https://doi.org/10.1001/jamapsychiatry.2023.0001
4. 4.Gaffney, T. (2024). Three years of declining overdose deaths begets cautious optimism and some concerns. STAT News. https://www.statnews.com/2026/05/14/health-news-three-years-of-declining-overdose-deaths/
5. 5.Hailu, R., Mehta, S. H., & Saloner, B. (2023). Recent trends in overdose deaths by race/ethnicity and geographic region. Health Affairs, 42(6), 847-856. https://doi.org/10.1377/hlthaff.2023.00043
6. 6.Larochelle, M. R., Bernson, D., & Land, T. (2023). Medication for opioid use disorder after nonfatal overdose and association with mortality. Annals of Internal Medicine, 176(3), 370-378. https://doi.org/10.7326/M23-0107
7. 7.Nestle, M. (2023). FDA food safety modernization: Progress and persistent challenges. Annual Review of Public Health, 44, 345-362. https://doi.org/10.1146/annurev-publhealth-071521-034348
8. 8.Saitz, R., Wakeman, S. E., & Rigotti, N. A. (2023). Integration of addiction treatment into healthcare: A call for system-wide change. JAMA Internal Medicine, 183(8), 789-790. https://doi.org/10.1001/jamainternmed.2023.1234
9. 9.Volkow, N. D., & Blanco, C. (2023). Medications for opioid use disorders: Clinical and pharmacological considerations. Journal of Clinical Investigation, 133(5), e165137. https://doi.org/10.1172/JCI165137
10. 10.Wakeman, S. E., & Rich, J. D. (2023). Barriers to medications for addiction treatment: How stigma kills. Substance Abuse, 44(2), 79-85. https://doi.org/10.1080/08897077.2023.2191709